Hany Zayed, Ph.D. is the head of Data Science Solutions group at Rigel Pharmaceuticals. He has more than 25 years’ experience in statistical analysis and consulting including design of clinical studies, data analysis and results interpretation. Hany has extensive experience in strategic clinical research including due diligence evaluations, post-approval clinical trials and disease/product registries. His special interest is in the development and analysis of patient reported outcomes, quality of life, treatment satisfaction and disease burden in areas including oncology, inflammatory/pain, cardiovascular, ophthalmology, endocrinology, infectious diseases, sexual dysfunction, central nervous system and several orphan/small populations.